Fortuna, Danielle <br/><br/>
Model analysis of effect of canagliflozin (Invokana), a sodium-glucose cotransporter 2 inhibitor, to alter plasma 1,5-anhydroglucitol.  [electronic resource] 

 -  Clinica chimica acta; international journal of clinical chemistry  Jan 2016 
 - 138-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3492 
<br/><br/><label>Standard No.: </label>10.1016/j.cca.2015.11.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Canagliflozin--pharmacology<br/>Deoxyglucose--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Humans<br/>Hypoglycemic Agents--pharmacology<br/>Models, Biological<br/>Sodium-Glucose Transporter 2<br/>Sodium-Glucose Transporter 2 Inhibitors